| Literature DB >> 35968202 |
Alberto Artiles Medina1, Victoria Gómez Dos Santos1, Víctor Díez Nicolás1, Vital Hevia Palacios1, Mercedes Ruiz Hernández1, Inés Laso García1, Marina Mata Alcaraz1, Cristina Galeano Álvarez2, Miguel Ángel Jiménez Cidre1, Fernando Arias Fúnez1, Milagros Fernández Lucas2, Francisco Javier Burgos Revilla1.
Abstract
Introduction: Transplantation surgery teams often have to face complex cases. In certain circumstances, such as occlusion of the iliac vessels or prior pelvic surgery, heterotopic kidney transplantation may not be feasible and orthotopic kidney transplantation (OKT) could be a good alternative. Kidney autotransplantation (KAT) has been described as a potential treatment for complex renovascular, ureteral, or neoplastic conditions. There are scarce data regarding the complications and outcomes of these procedures; therefore, we present our experience. Materials andEntities:
Year: 2022 PMID: 35968202 PMCID: PMC9366201 DOI: 10.1155/2022/9299397
Source DB: PubMed Journal: Adv Urol ISSN: 1687-6369
Figure 1Indications for orthotopic kidney transplantation (OKT). OKT was used in kidney transplant recipients with a prior urinary diversion in our initial experience.
Figure 2Indications for kidney autotransplantation (KAT).
Donors' characteristics.
| Variable | Value |
|---|---|
| Donor age in years, mean (SD) | 69.2 (14.53) |
| Donor terminal serum creatinine, mean (SD) | 0.77 (0.23) |
| Proportion of glomerulosclerosis, mean (SD) | 7.5 (4.89) |
| Cold ischemia time, hours, mean (SD) | 18.59 (2.21) |
Baseline characteristics.
| Variable | Value |
|---|---|
| Age in years, mean (SD) | 52.66 (13.99) |
| Female vs male, | 5 (23.81%) vs 16 (76.19%) |
| aCCI, mean (SD) | 4.47 (1.96) |
|
| |
| Number of prior transplants | |
| 0 | 15 (71.43%) |
| 1 | 2 (9.52%) |
| 2 | 2 (9.52%) |
| 3 | 1 (4.76%) |
| 5 | 1 (4.76%) |
|
| |
| ESRD causes | |
| Diabetic nephropathy | 4 (19.05%) |
| Interstitial nephritis | 4 (19.05%) |
| Unknown origin | 3 (14.29%) |
| Glomerulopathies | 5 (23.81%) |
| Nephroangiosclerosis | 1 (4.76%) |
| Cyclosporine nephropathy | 1 (4.76%) |
| Kidney dysplasia | 1 (4.76%) |
| Others (secondary to obstructive uropathy or reflux nephropathy) | 2 (9.52%) |
Indications of OKTs and surgical data.
| Variable | Value |
|---|---|
| Indication | |
| Unsuitable iliac region due to vascular abnormality | 12 (57.14%) |
| Unsuitable iliac region due to prior transplantations | 4 (19.05%) |
| | 5 (23.81%) |
| Ileal conduit | 4 |
| Cutaneous ureterostomy | 1 |
| Arterial anastomosis | |
| Donor renal artery to the native splenic artery | 20 (95.24%) |
| Donor renal artery to the aorta | 1 (4.76%) |
| Venous anastomosis | |
| Donor renal vein to the native renal vein | 18 (85.71%) |
| Donor renal vein to the native splenic vein | 2 (9.52%) |
| Donor renal vein to the inferior cava vein | 1 (4.76%) |
| Urinary reconstruction | |
| Ureteroureterostomy | 14 (66.67%) |
| Pyelopyelostomy | 6 (28.57%) |
| Pyeloureterostomy | 0 |
| Ureteric implantation in ileal conduit | 1 (4.71%) |
| Operation time, min, mean (SD) | 283.46 (70.22) |
Early and late postoperative complications of OKT.
| Variable | Value |
|---|---|
| Early postoperative complications (≤30 days) | 14 (66.67%) |
|
| |
|
| |
| (i) Arterial thrombosis that required transplantectomy, | 2 |
| (ii) Hypoperfusion that required transplantectomy, | 1 |
| (iii) Bleeding, | 1 |
| (iv) Acute urinary retention after urinary catheter removal, | 2 |
| (v) Perigraft fluid collection, | 1 |
| (vi) Urinary leak, | 1 |
| (vii) Surgical site infection, | 1 |
|
| |
|
| |
| (i) Decompensated heart failure, | 1 |
| (ii) Gastrointestinal bleeding, | 1 |
| (iii) Febrile urinary tract infection, | 1 |
| (iv) Respiratory septic shock (ventilator-associated pneumonia), | 1 |
| (v) acute rejection, | 1 |
|
| |
| Early postoperative complications (≤30 days) according to Clavien-Dindo classification | |
| 2 | 6 (28.57%) |
| 3a | 2 (9.52%) |
| 3b | 5 (23.81%) |
| 5 | 1 (4.76%) |
|
| |
| Hospital stay, mean (SD) | 14.36 (7.08) |
| Time to double | 25.85 (14.68) |
| Late postoperative complications (>30 days) | 6 (28.57%) |
|
| |
|
| |
| (i) Obstructive lymphocele, | 1 |
| (ii) Pancreatic fistula, | 1 |
|
| |
|
| |
| (i) Septic shock secondary to pyelonephritis, | 1 |
| (ii) Clostridium difficile associated diarrhoea, | 1 |
| (iii) Urinary tract infection, | 1 |
| (iv) Graft rejection, | 1 |
|
| |
| Late postoperative complications (>30 days) according to Clavien-Dindo classification | |
| 2 | 3 (13.21%) |
| 3a | 1 (4.76%) |
| 3b | 1 (4.76%) |
| 5 | 1 (4.76%) |
OKT outcomes.
| Variable | Value |
|---|---|
| Mean follow-up in years | 5.76 (6.15) |
| Immediate graft function, | 13 (61.90%) |
| DGF, | 8 (38.09%) |
| PNF, | 0 |
|
| 3 (14.28%) |
|
| |
|
| |
| Creatinine level, mean (SD) | 2.02 (0.91) |
| eGFR at discharge, mean (SD) | 45.28 (24.17) |
|
| |
|
| |
| Creatinine level, mean (SD) | 1.79 (0.66) |
| eGFR, mean (SD) | 43.95 (17.75) |
|
| |
|
| |
| Creatinine level, mean (SD) | 2.41 (3.01) |
| eGFR at 1 year after surgery, mean (SD) | 47.53 (SD 27.04) |
|
| |
|
| |
| Creatinine level, mean (SD) | 1.47 (SD 0.24) |
| eGFR, mean (SD) | 46.28 (SD 6.83) |
|
| |
| Overall mortality, | 7 (33.33%) |
|
| |
|
| |
| Gastrointestinal bleeding, | 1 |
| Septic shock, | 2 |
| Cardiac arrest, | 1 |
| Melanoma, | 1 |
| Intestinal obstruction, | 1 |
| Acute arterial limb ischemia, | 1 |
|
| |
| Functioning graft, | 12 (66.67%) |
| Graft loss, | 9 (42.85%) |
| Graft rejection, | 3 (14.29%) |
Figure 3Kaplan–Meier survival curve showing non-death-censored graft survival of OKT grafts.
Baseline characteristics of the KAT series.
| Variable | Value |
|---|---|
| Age in years, mean (SD) | 48.33 (17.36) |
| aCCI, mean (SD) | 2.44 (2.60) |
| Preoperative creatinine, mean (SD) | 1.04 (SD 0.38) |
| Preoperative eGFR, mean (SD) | 78.96 (SD 36.88) |
| Solitary kidney, | 3 (15.78%) |
excluded pediatric patients.
Indications of KATs and surgical data.
| Variable | Value |
|---|---|
| Indication | |
|
| 10 (52.63%) |
| Following open surgery | 4 |
| Following ureteroscopy | 4 |
| Secondary to retroperitoneal fibrosis | 1 |
| Secondary to Crohn's disease | 1 |
|
| 8 (42.11%) |
| Renal artery stenosis, | 4 |
| Renal artery fibromuscular dysplasia, | 2 |
| Takayasu disease, | 1 |
| Renal artery aneurysm, | 1 |
|
| 1 (5.26%) |
|
| |
| Nephrectomy approach, | |
| Open | 15 (78.94%) |
| Laparoscopic | 4 (21.05%) |
| Operation time, min, mean (SD) | 390 (165.87) |
| Ureteral disinsertion | 13 (68.42%) |
|
| |
|
| |
| Ureteroneocystostomy | |
| (i) Direct reimplantation, | 2 (15.38%) |
| (ii) Extravesical technique, | 10 (76.92%) |
| Ureteroureterostomy, | 1 (7.69%) |
| Cold ischemia time, min, mean (SD) | 84.28 (67.84) |
Early and late postoperative complications of KAT.
| Variable | Value |
|---|---|
| Early postoperative complications (≤30 days) | 8 (42.11%) |
|
| |
|
| |
| Surgical site infection | |
| Superficial | 2 |
| Deep | 1 |
| Thrombosis of renal vein, | 1 |
| Arterial thrombosis, | 1 |
|
| |
|
| |
| Acute tubular necrosis, | 1 |
| Decompensated heart failure, | 1 |
| Fever of unknown origin, | 1 |
|
| |
| Hospital stay, days, mean (SD) | 10.44 (5.38) |
|
| |
| Early postoperative complications (≤30 days) according to Clavien-Dindo classification | |
| 1 | 5 (26.32%) |
| 2 | 2 (10.53%) |
| 3b | 1 (5.26%) |
|
| |
| Late postoperative complications (>30 days) | |
| Obstructive uropathy, | 1 (5.26%) |
| Late postoperative complications (>30 days) according to Clavien-Dindo classification | 1 |
| 3a | 1 (5.26%) |
KAT outcomes.
| Variable | Value |
|---|---|
| Mean follow-up in years | 4.47 |
| Acute tubular necrosis in the immediate postoperative period, | 3 (15.79%) |
|
| |
|
| |
| Creatinine level, mean (SD) | 0.97 (0.47) |
| eGFR, mean (SD) | 91.43 (38.06) |
|
| |
|
| |
| Creatinine level, mean (SD) | 1.18 (0.34) |
| eGFR, mean (SD) | 70.83 (SD 24.49) |
|
| |
|
| |
| Creatinine level, mean (SD) | 1.07 (SD 0.24) |
| eGFR, mean (SD) | 76.94 (SD 20.82) |
|
| |
| Creatinine level at 1 year after surgery in patients with solitary kidney ( | 1.25 (SD 0.41) |
| eGFR at 1 year after surgery in patients with solitary kidney ( | 64.92 (SD 29.06) |
|
| |
| Overall mortality, | 0 |
| Functioning graft, | 15 (78.94%) |
| Graft loss during follow-up, | 4 (15.79%) |
|
| |
|
| |
| (i) Arterial thrombosis | 1 |
| (ii) Venous thrombosis | 1 |
|
| |
|
| |
| (i) Obstructive uropathy | 1 |
| (ii) Unknown origin | 1 |
| Clinically significant stenosis in the arterial anastomosis, | 0 |
Largest series of OKT published in the literature to date.
| Author | Year | Sample | Indications | Complication rate | Graft survival |
|---|---|---|---|---|---|
| Gil-Vernet et al. [ | 1989 | 139 | Alternative to HKT (elective surgery) | Vascular: 4/139 (2.8%) | Graft loss rate: 7/139 (5%) |
| Urinary: 5/139 (2.8%) | |||||
|
| |||||
| Paduch et al. [ | 2001 | 5 | Severe iliac atherosclerosis: 3 | NA | Graft survival: 100% during follow-up (from 6 months to 5 years) |
| Retained bilateral iliac fossa kidney transplant: 2 | |||||
|
| |||||
| Rodrigues et al. [ | 2004 | 4 | Bilateral occlusion of common iliac arteries: 4 | NA | Graft survival: 100% (9 days–14 months) |
|
| |||||
| Musquera et al. [ | 2010 | 223 ( | Severe iliac atherosclerosis: 41.7% | Vascular: 13/84 (9.6%) | Graft survival at 1 year: 86.4% |
| Bilaterally retained iliac fossae from a previous kidney transplant: 28.9% | Urinary: 16/84 (19.1%) | ||||
| Elective: 4.5% | |||||
|
| |||||
| Hevia et al. [ | 2014 | 9 | Unsuitable iliac region: 67% | Early: 33.3% (3/9) | Graft survival at 1 year: 88.9% |
| LUT abnormalities/urinary diversion: 33% | Late: 22.2% (2/9) | ||||
|
| |||||
| Chan et al. [ | 2019 | 3 | IVC thrombosis or stenosis | Early: 100% (2 Clavien grade 2 and 1 Clavien grade 3a) | NA |
Figure 4(a). Important aortoiliac calcification. (b). Arteriography showing left external iliac artery stenosis. (c). Bilateral occupation of the iliac fossae by prior kidney grafts.
Figure 5A CT reconstruction showing aortoiliac vascular occlusion and calcified splenic artery. This is a complex case that could require the anastomoses to the native renal vessels.
Figure 6(a and b) represent the CT angiography (reconstruction) in a challenging case of a patient with a left external and common iliac artery chronic total occlusion who underwent femorofemoral bypass. In this case, transplantation in the intact right iliac artery segment (43.1 mm) could be associated with vascular steal following heterotopic transplantation. The image C corresponds to the post-OKT CT angiography.
Largest published series of KAT.
| Author | Year | Sample | Indications | Complication rate | Graft loss |
|---|---|---|---|---|---|
| Chiche et al. [ | 2003 | 57 | Vascular pathology: Fibromuscular dysplasia for 34 RAT procedures in 30 patients, Takayasu's disease for 26, and others | 9/57 (15.79%) | 8/57 (14.04%) |
|
| |||||
| Tran et al. [ | 2015 | 52 | Vascular pathology: 3.8% | 4 patients had early complications and 8 had late complications | 5/52 (9.61%) |
| Ureteral pathology: 78.8% | |||||
| Malignancy: 13.4% | |||||
|
| |||||
| Cowan et al. [ | 2015 | 51 | Vascular anomalies: 18.5% | Overall: 12.9% | 2/51 (3.92%) |
| Loin pain hematuria syndrome/chronic kidney pain: 31.5% Ureteral stricture: 20.4% | Grade 3a or greater: 14.8% | ||||
|
| |||||
| Duprey et al. [ | 2016 | 65 | Renal artery branch aneurysms | 12 (18%) major postoperative complications | 8/65 (12.3%) |
|
| |||||
| Moghadamyeghaneh et al. [ | 2017 | 817 | Vascular pathology: 22.7% | 46.2% | 10.7% |
| Ureteral pathology: 17% | |||||
| Malignancy: 14.9% | |||||
Figure 7(a). Antegrade pyelography showing ureteral stop secondary to an iatrogenic ureteral lesion during open surgery. (b) and (c). Three-dimensional computed tomography reconstruction of the artery Ao, abdominal aorta. (d) Sagittal CT image showing KAT location and vasculature.
Figure 8(a). CT scan showing an orthotopic kidney transplantation with the venous reconstruction of the left renal vein. (b) (adapted from Hevia et al.) and (c) are a reconstructed CT image of the urinary system and intravenous urography, respectively, representing a ureteroureterostomy in orthotopic renal transplantation in a patient with a history of myelomeningocele and cystectomy with cutaneous ureterostomy.